Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in ...

New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an ...

A patient with type 1 diabetes received genetically modified allogeneic islets and no immunosuppression. Results obtained ...

Gross SC-islet morphology and size were maintained, yet the fraction of NKX6.1-positive β cells fell substantially, pointing ...

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...

NewcelX ( (NCEL)) has provided an update. On July 8, 2026, NewcelX appointed world-renowned diabetes and cellular transplantation expert Dr. Camillo Ricordi to its Scientific Advisory Board, ...

The International Society for Stem Cell Research (ISSCR) today announced the presentation of new clinical data from the ...

Medical history is being made right here in central Indiana as the world’s first successful pediatric bone marrow transplant ...

Century Therapeutics (IPSC) downgraded to Hold after CNTY-101 halted and slow clinical progress. Click here to read my most ...

The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway ...

In June, thousands of diabetes scientists from around the world gathered in New Orleans for the American Diabetes Association (ADA) Scientific Meeting. Here are some of their updates. More from our ...